Brief: Onward Medical End-March Cash And Cash Equivalents At EUR 42.0 Mln

ONWARD Medical

23/05/2024 08:12

May 23 (Reuters) - Onward Medical NV  ONWD.BR :
    * ONWARD® MEDICAL REPORTS Q1 2024 UPDATE AND YEAR-TO-DATE
HIGHLIGHTS
    * CASH AND CASH EQUIVALENTS OF EUR 42 MILLION AS OF MARCH
31, 2024
    * GROUP REAFFIRMED ITS EXPECTED CASH RUNWAY THROUGH MID-2025
    * COMPANY EXPECTS FDA CLEARANCE AND FIRST COMMERCIAL SALE IN
US
FOR ITS ARC-EX SYSTEM SOMETIME IN Q4 2024
    * EUROPEAN REGULATORY APPROVAL AND COMMERCIALIZATION ARE
EXPECTED
SOMETIME IN 2025.
    * ONWARD MEDICAL EXPECTS PUBLICATION OF INTERIM RESULTS FROM
CLINICAL FEASIBILITY STUDIES FOR THIS INDICATION IN A LEADING
SCIENTIFIC JOURNAL SOMETIME IN 2H 2024
    * ONWARD MEDICAL EXPECTS TO GAIN ADDITIONAL CLINICAL DATA
AND
EXPERIENCE WITH ITS IMPLANTABLE ARC-IM SYSTEM IN 2024

Source text for WorkSpace:  urn:newsml:reuters.com:*:nGNE9QDtKy
Further company coverage:  ONWD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))